Definitive Contract 75F40120C00199
Award Date 9/29/20
Potential Completion Date 8/31/23
Potential Value $1.1M
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Tucson, AZ 85718, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a definitive contract awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to The Critical Path Institute (C-Path), a non-profit organization. The contract, which does not have a set-aside designation, is for $1,594,872.00 and is for the development of novel kidney transplant drug development tools to enhance regulatory decision making and enable innovation in medical product development. The contract was awarded on September 19, 2018, with a...
- This federal contract award is for $4,418,256.96 to The Critical Path Institute (C-Path), a non-profit organization, by the Food and Drug Administration (FDA). The contract was awarded under the FDA's Broad Agency Announcement (BAA) EETWP #63 to develop "A STANDARDIZED FRAMEWORK TO SUPPORT FDA QUALIFICATION OF COMPLEX IN VITRO MODELS FOR USE IN REGULATORY SUBMISSIONS." The BAA solicits research and development proposals to advance regulatory science in various areas of interest for...
- This is a $787,013 cost-reimbursement contract awarded by the Food and Drug Administration (FDA) to The Critical Path Institute (C-Path), a non-profit organization, for the "Clinical Evaluation and Qualification of Translational Kidney Safety Biomarkers." The contract, which does not have a set-aside designation, was awarded on September 8, 2016 and has a completion date of June 29, 2019. C-Path's work under this contract involves collaborating with industry, academia, and patient...
- The Food and Drug Administration (FDA) awarded a definitive, cost-no-fee contract valued at $2.74 million to The Critical Path Institute (C-Path), a non-profit research organization based in Tucson, Arizona, under a Broad Agency Announcement (BAA) solicitation. The contract, awarded on September 30, 2019, supported the development of novel clinical outcome assessments for pediatric asthma to facilitate innovative, patient-focused drug development and aid regulatory decision-making. C-Path, which...
- This is a definitive, firm fixed-price federal contract awarded by the Food and Drug Administration (FDA) to the non-profit organization The Critical Path Institute (C-Path), doing business as C-Path. The contract, which is not set aside for specific business types, has a ceiling value of $3,376,000.00 and a completion date of August 21, 2028. The contract is for the development of drug development tools for autosomal dominant tubulointerstitial kidney disease (ADTKD). C-Path, the prime...
- Toxicologic Pathology Associates Inc. was awarded a $20.7 million definitive contract by the Department of Health and Human Services' Food and Drug Administration to provide onsite pathology services from July 2015 through July 2020. The contract has a small business set aside designation. As part of its mission to protect public health, the FDA utilizes pathology expertise to evaluate samples for issues impacting medical products and the safety of the food supply. This award draws on the...
- This is a $1,904,355.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA), a civilian government agency, to the Institute Of Quantitative Systems Pharmacology, a non-profit organization. The contract is for basic and applied research with two key objectives: (1) to test the hypothesis that variabilities in nanoparticle (NP) properties and tumor targets cause uncertainties in "FORMULA", and (2) to develop computational models to predict the...
- The Department of Health and Human Services Food and Drug Administration awarded a $84,490.00 firm fixed price purchase order contract to the Clinical Data Interchange Standards Consortium Inc. (Cdisc), a non-profit organization. The contract is for CDISC membership services, including Cdisc training, support for clinical research data standards and technical resources, and activities supporting common data model harmonization and FHIR to generate clinical evidence from real-world data for...
- This delivery order, awarded by the Department of Health and Human Services' Food and Drug Administration, is valued at one hundred sixty-three thousand three hundred ninety-three dollars and fifty cents ($163,393.50) to provide knowledge and risk management maturity towards 21st century goals. Caitta Inc., an 8A Small Business Administration-certified participant, will serve as the prime contractor performing work in Silver Spring, Maryland under a firm fixed price contract structure running...
- This is a $1,299,218.00 Definitive Contract awarded by the Food and Drug Administration (FDA) to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract is for "BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS" and has a period of performance through February 2, 2026. The contract is a Time and Materials type with no set-aside designation. PPD...